Symbio Pharmaceuticals Limited's total assets for Q1 2025 were ¥4.67B, a decrease of -6.06% from the previous quarter. JP:4582 total liabilities were ¥1.27B for the fiscal quarter, a 64.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.